A detailed history of Met Life Investment Management, LLC transactions in Penumbra Inc stock. As of the latest transaction made, Met Life Investment Management, LLC holds 21,720 shares of PEN stock, worth $5.17 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
21,720
Previous 22,088 1.67%
Holding current value
$5.17 Million
Previous $3.98 Million 6.09%
% of portfolio
0.02%
Previous 0.02%

Shares

70 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$163.64 - $210.12 $60,219 - $77,324
-368 Reduced 1.67%
21,720 $4.22 Million
Q2 2024

Aug 13, 2024

SELL
$172.27 - $223.95 $98,193 - $127,651
-570 Reduced 2.52%
22,088 $3.98 Million
Q1 2024

May 14, 2024

BUY
$220.09 - $273.15 $4.99 Million - $6.19 Million
22,658 New
22,658 $5.06 Million
Q4 2023

Feb 14, 2024

SELL
$181.44 - $260.22 $51,347 - $73,642
-283 Reduced 1.2%
23,212 $5.84 Million
Q3 2023

May 09, 2024

SELL
$240.69 - $338.77 $281,366 - $396,022
-1,169 Reduced 4.74%
23,495 $5.68 Million
Q3 2023

Apr 29, 2024

SELL
$240.69 - $338.77 $216,861 - $305,231
-901 Reduced 3.69%
23,495 $5.68 Million
Q3 2023

Nov 14, 2023

SELL
$240.69 - $338.77 $216,861 - $305,231
-901 Reduced 3.69%
23,495 $5.68 Million
Q2 2023

Apr 29, 2024

BUY
$271.54 - $344.06 $6.62 Million - $8.39 Million
24,396 New
24,396 $8.39 Million
Q2 2023

Aug 10, 2023

SELL
$271.54 - $344.06 $72,772 - $92,208
-268 Reduced 1.09%
24,396 $8.39 Million
Q1 2023

May 09, 2024

BUY
$220.43 - $278.69 $5.44 Million - $6.87 Million
24,664 New
24,664 $6.87 Billion
Q1 2023

May 15, 2023

SELL
$220.43 - $278.69 $136,446 - $172,509
-619 Reduced 2.45%
24,664 $6.87 Million
Q4 2022

May 10, 2024

SELL
$151.88 - $228.5 $73,358 - $110,365
-483 Reduced 1.87%
25,283 $5.62 Million
Q4 2022

Jun 14, 2023

BUY
$151.88 - $228.5 $94,013 - $141,441
619 Added 2.51%
25,283 $5.62 Million
Q4 2022

Mar 22, 2023

SELL
$151.88 - $228.5 $73,358 - $110,365
-483 Reduced 1.87%
25,283 $5.62 Million
Q4 2022

Feb 15, 2023

SELL
$151.88 - $228.5 $73,358 - $110,365
-483 Reduced 1.87%
25,283 $5.62 Million
Q3 2022

May 10, 2024

BUY
$120.36 - $205.88 $152,857 - $261,467
1,270 Added 5.18%
25,766 $4.89 Million
Q3 2022

Jun 14, 2023

BUY
$120.36 - $205.88 $132,636 - $226,879
1,102 Added 4.47%
25,766 $4.89 Million
Q3 2022

Mar 22, 2023

BUY
$120.36 - $205.88 $152,857 - $261,467
1,270 Added 5.18%
25,766 $4.89 Million
Q3 2022

Nov 14, 2022

BUY
$120.36 - $205.88 $152,857 - $261,467
1,270 Added 5.18%
25,766 $4.89 Million
Q2 2022

May 10, 2024

BUY
$116.09 - $227.33 $28,790 - $56,377
248 Added 1.02%
24,496 $3.05 Million
Q2 2022

Jun 20, 2023

SELL
$116.09 - $227.33 $19,503 - $38,191
-168 Reduced 0.68%
24,496 $3.05 Million
Q2 2022

Mar 22, 2023

BUY
$116.09 - $227.33 $28,790 - $56,377
248 Added 1.02%
24,496 $3.05 Million
Q2 2022

Aug 11, 2022

BUY
$116.09 - $227.33 $28,790 - $56,377
248 Added 1.02%
24,496 $3.05 Million
Q1 2022

May 10, 2024

BUY
$187.51 - $283.98 $4.55 Million - $6.89 Million
24,248 New
24,248 $5.39 Million
Q1 2022

Jun 20, 2023

SELL
$187.51 - $283.98 $78,004 - $118,135
-416 Reduced 1.69%
24,248 $5.39 Million
Q1 2022

Mar 22, 2023

BUY
$187.51 - $283.98 $1.36 Million - $2.05 Million
7,229 Added 42.48%
24,248 $5.39 Million
Q1 2022

May 12, 2022

BUY
$187.51 - $283.98 $1.36 Million - $2.05 Million
7,229 Added 42.48%
24,248 $5.39 Million
Q4 2021

May 17, 2024

BUY
$238.08 - $288.0 $118,801 - $143,712
499 Added 3.02%
17,019 $4.89 Million
Q4 2021

Jun 21, 2023

SELL
$238.08 - $288.0 $1.82 Million - $2.2 Million
-7,645 Reduced 31.0%
17,019 $4.89 Million
Q4 2021

Mar 22, 2023

BUY
$238.08 - $288.0 $118,801 - $143,712
499 Added 3.02%
17,019 $4.89 Million
Q4 2021

Feb 15, 2022

BUY
$238.08 - $288.0 $118,801 - $143,712
499 Added 3.02%
17,019 $4.89 Million
Q3 2021

May 17, 2024

SELL
$250.72 - $291.24 $108,561 - $126,106
-433 Reduced 2.55%
16,520 $4.4 Million
Q3 2021

Jun 21, 2023

SELL
$250.72 - $291.24 $2.04 Million - $2.37 Million
-8,144 Reduced 33.02%
16,520 $4.4 Million
Q3 2021

Mar 22, 2023

SELL
$250.72 - $291.24 $108,561 - $126,106
-433 Reduced 2.55%
16,520 $4.4 Million
Q3 2021

Nov 15, 2021

SELL
$250.72 - $291.24 $108,561 - $126,106
-433 Reduced 2.55%
16,520 $4.4 Million
Q2 2021

May 17, 2024

SELL
$235.0 - $310.7 $130,895 - $173,059
-557 Reduced 3.18%
16,953 $4.65 Million
Q2 2021

Jun 21, 2023

SELL
$235.0 - $310.7 $1.81 Million - $2.4 Million
-7,711 Reduced 31.26%
16,953 $4.65 Million
Q2 2021

Mar 22, 2023

SELL
$235.0 - $310.7 $130,895 - $173,059
-557 Reduced 3.18%
16,953 $4.65 Million
Q2 2021

Aug 16, 2021

SELL
$235.0 - $310.7 $130,895 - $173,059
-557 Reduced 3.18%
16,953 $4.65 Million
Q1 2021

May 17, 2024

SELL
$175.6 - $291.43 $903,988 - $1.5 Million
-5,148 Reduced 22.72%
17,510 $4.74 Million
Q1 2021

Jun 26, 2023

SELL
$175.6 - $291.43 $1.26 Million - $2.08 Million
-7,154 Reduced 29.01%
17,510 $4.74 Billion
Q1 2021

Mar 22, 2023

SELL
$175.6 - $291.43 $170,156 - $282,395
-969 Reduced 5.24%
17,510 $4.74 Million
Q1 2021

May 14, 2021

SELL
$175.6 - $291.43 $170,156 - $282,395
-969 Reduced 5.24%
17,510 $4.74 Million
Q4 2020

May 24, 2024

SELL
$174.98 - $272.83 $130,710 - $203,804
-747 Reduced 3.89%
18,479 $3.23 Million
Q4 2020

Jun 22, 2023

SELL
$174.98 - $272.83 $1.08 Million - $1.69 Million
-6,185 Reduced 25.08%
18,479 $3.23 Million
Q4 2020

Mar 22, 2023

SELL
$174.98 - $272.83 $130,710 - $203,804
-747 Reduced 3.89%
18,479 $3.23 Million
Q4 2020

Feb 16, 2021

SELL
$174.98 - $272.83 $130,710 - $203,804
-747 Reduced 3.89%
18,479 $3.23 Million
Q3 2020

May 24, 2024

SELL
$185.27 - $238.73 $75,590 - $97,401
-408 Reduced 2.08%
19,226 $3.74 Billion
Q3 2020

Jun 26, 2023

SELL
$185.27 - $238.73 $1.01 Million - $1.3 Million
-5,438 Reduced 22.05%
19,226 $3.74 Million
Q3 2020

Mar 22, 2023

SELL
$185.27 - $238.73 $75,590 - $97,401
-408 Reduced 2.08%
19,226 $3.74 Million
Q3 2020

Nov 13, 2020

SELL
$185.27 - $238.73 $75,590 - $97,401
-408 Reduced 2.08%
19,226 $3.74 Million
Q2 2020

May 24, 2024

SELL
$153.32 - $191.72 $463,639 - $579,761
-3,024 Reduced 13.35%
19,634 $3.51 Billion
Q2 2020

Jun 26, 2023

SELL
$153.32 - $191.72 $771,199 - $964,351
-5,030 Reduced 20.39%
19,634 $3.51 Million
Q2 2020

Mar 22, 2023

BUY
$153.32 - $191.72 $183,370 - $229,297
1,196 Added 6.49%
19,634 $3.51 Million
Q2 2020

Aug 14, 2020

BUY
$153.32 - $191.72 $183,370 - $229,297
1,196 Added 6.49%
19,634 $3.51 Million
Q1 2020

Jul 12, 2023

SELL
$124.34 - $193.76 $774,140 - $1.21 Million
-6,226 Reduced 25.24%
18,438 $2.97 Million
Q4 2019

Jul 12, 2023

SELL
$134.81 - $177.8 $839,327 - $1.11 Million
-6,226 Reduced 25.24%
18,438 $3.03 Million
Q4 2019

Mar 22, 2023

SELL
$134.81 - $177.8 $24,265 - $32,004
-180 Reduced 0.97%
18,438 $3.03 Million
Q4 2019

Feb 14, 2020

SELL
$134.81 - $177.8 $24,265 - $32,004
-180 Reduced 0.97%
18,438 $3.03 Million
Q3 2019

Jul 12, 2023

SELL
$131.82 - $183.4 $796,983 - $1.11 Million
-6,046 Reduced 24.51%
18,618 $2.5 Million
Q3 2019

Mar 22, 2023

BUY
$131.82 - $183.4 $2.45 Million - $3.41 Million
18,576 Added 44228.57%
18,618 $2.5 Million
Q3 2019

Nov 14, 2019

BUY
$131.82 - $183.4 $2.45 Million - $3.41 Million
18,618 New
18,618 $2.5 Million
Q2 2019

Aug 14, 2019

SELL
$124.65 - $167.39 $5,235 - $7,030
-42 Closed
0 $0
Q1 2019

Jul 13, 2023

SELL
$115.84 - $160.31 $2.85 Million - $3.95 Million
-24,622 Reduced 99.83%
42 $6,000
Q4 2018

Jul 13, 2023

SELL
$113.42 - $156.48 $2.79 Million - $3.85 Million
-24,622 Reduced 99.83%
42 $5,000
Q3 2018

Jul 13, 2023

SELL
$121.55 - $156.8 $2.99 Million - $3.86 Million
-24,622 Reduced 99.83%
42 $6,000
Q3 2018

Mar 22, 2023

SELL
$121.55 - $156.8 $3.07 Million - $3.96 Million
-25,241 Reduced 99.83%
42 $6,000
Q3 2018

Nov 14, 2018

BUY
$121.55 - $156.8 $5,105 - $6,585
42 New
42 $6,000
Q2 2018

Aug 15, 2018

SELL
$112.2 - $165.95 $1.48 Million - $2.19 Million
-13,208 Closed
0 $0
Q4 2017

Feb 15, 2018

BUY
$91.55 - $115.85 $1.21 Million - $1.53 Million
13,208
13,208 $1.24 Million

Others Institutions Holding PEN

About Penumbra Inc


  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $9.01B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.